T. August

发表

Human Leukocyte Antigen (HLA) Class I Restricted Epitope Discovery in Yellow Fewer and Dengue Viruses: Importance of HLA Binding Strength

Morten Nielsen, Ole Lund, Ernesto T. A. Marques, 2011, PloS one.

Dengue 2 PreM-E/LAMP chimera targeted to the MHC class II compartment elicits long-lasting neutralizing antibodies.

I. C. Leão, C. Chougnet, G. Murphy, 2003, Vaccine.

New technologies for vaccine development

V. Brusic, T. August, K. N. Srinivasan, 2004 .

Purification and partial amino acid sequence analysis of human erythrocyte acetylcholinesterase

T. August, B. Earles, V. Chhajlani, 1989, FEBS letters.

Combination of drug and gene delivery by gelatin nanospheres for the treatment of cystic fibrosis

T. Flotte, K. Leong, S. Beck, 1997 .

Delivery of DNA vaccine using gelatin-DNA nanospheres

K. Leong, H. Mao, V. Truong-Le, 1997 .

Immunization of neonatal mice with LAMP/p55 HIV gag DNA elicits robust immune responses that last to adulthood.

A. J. da Silva Duarte, M. Maciel, T. August, 2010, Virology.

Evaluation of Novel Human Immunodeficiency Virus Type 1 Gag DNA Vaccines for Protein Expression in Mammalian Cells and Induction of Immune Responses

G. Pavlakis, C. Tian, Xiao-Fang Yu, 1999, Journal of Virology.

The use of immunoprecipitation to study the synthesis and cleavage processing of viral proteins.

T. August, S. Z. Shapiro, 1976, Journal of immunological methods.

Correction: Human Leukocyte Antigen (HLA) Class I Restricted Epitope Discovery in Yellow Fewer and Dengue Viruses: Importance of HLA Binding Strength

O. Lund, C. Lundegaard, M. Nielsen, 2011, PLoS ONE.

Comprehensive analysis of T cell epitope discovery strategies using 17DD yellow fever virus structural proteins and BALB/c (H2d) mice model

J. Sidney, A. Sette, Srinivasan N. Kellathur, 2008, Virology.

The Enhanced Immune Response to the HIV gp160/LAMP Chimeric Gene Product Targeted to the Lysosome Membrane Protein Trafficking Pathway*

R. Siliciano, F. Guarnieri, T. August, 1997, The Journal of Biological Chemistry.

Membrane and envelope virus proteins co-expressed as lysosome associated membrane protein (LAMP) fused antigens: a potential tool to develop DNA vaccines against flaviviruses.

M. Maciel, T. August, E. Marques, 2009, Anais da Academia Brasileira de Ciencias.

Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.

K. Porter, T. Kochel, G. Murphy, 2001, Virology.

SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens

V. Brusic, J. Salmon, Vandana Gupta, 2006, Virology.

Murine Cell Surface Glycoproteins

G. Mengod, T. August, Hughes, 2001 .

Protective immunity of single and multi-antigen DNA vaccines against schistosomiasis.

I. C. Leão, T. August, P. Chikhlikar, 2002, Memorias do Instituto Oswaldo Cruz.

Monoclonal antibodies against a glycoprotein localized in coated pits and endocytic vesicles inhibit alpha 2-macroglobulin binding and uptake.

I. Pastan, M. Willingham, J. Hanover, 1986, The Journal of biological chemistry.

Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells.

R. Siliciano, F. Guarnieri, X. Lin, 1995, Journal of immunology.